28 results on '"Goodspeed, Wendy"'
Search Results
2. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis
3. Opportunistic Infections, Mortality Risk, and Prevention Strategies in Patients With Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome.
4. Physician Global Assessment as a Disease Activity Measure for Relapsing Polychondritis
5. Thrombotic Manifestations in Patients with Vexas Syndrome
6. A prospective observational cohort study and systematic review of 40 patients with mouth and genital ulcers with inflamed cartilage (MAGIC) syndrome
7. Discordance in patient and physician global assessment in relapsing polychondritis
8. Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors
9. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS
10. Clinical Manifestations Are Evolving and Progressive in Patients with Vexas Syndrome
11. Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma
12. Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors
13. Phase II Trial of Pirfenidone in Children and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
14. Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease
15. Discordance in patient and physician global assessment in relapsing polychondritis.
16. Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: A report from the Childrenʼs Oncology Group
17. Defining Clinical Subgroups in Relapsing Polychondritis: A Prospective Observational Cohort Study
18. Utility of the Brief Illness Perception Questionnaire to Monitor Patient Beliefs in Systemic Vasculitis
19. 244. RELAPSING POLYCHONDRITIS PATIENTS WITH TRACHEOMALACIA HAVE A LOWER FEV1/FVC AND FEF 25-75% AS WELL AS A PREVIOUS DIAGNOSIS OF ASTHMA
20. 243. CLINICAL FEATURES AND PULMONARY FUNCTION TEST FINDINGS ASSOCIATED WITH LARGE AIRWAY DISEASE IN RELAPSING POLYCHONDRITIS
21. Phase I trial and pharmacokinetic (PK) study of satraplatin in children and young adults with refractory solid tumors including brain tumors.
22. A Phase 1 Trial and Pharmacokinetic Study of Cediranib, an Orally Bioavailable Pan–Vascular Endothelial Growth Factor Receptor Inhibitor, in Children and Adolescents With Refractory Solid Tumors
23. Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: A report from the Children's Oncology Group
24. Phase II Trial of Ixabepilone Administered Daily for Five Days in Children and Young Adults with Refractory Solid Tumors: A Report from the Children's Oncology Group
25. Abstract A5: Phase I trial and pharmacokinetic study of cediranib in children with recurrent or refractory solid tumors
26. Phase I Trial and Pharmacokinetic Study of Ixabepilone Administered Daily for 5 Days in Children and Adolescents With Refractory Solid Tumors
27. A Phase I Study of ABT-751, an Orally Bioavailable Tubulin Inhibitor, Administered Daily for 21 Days Every 28 Days in Pediatric Patients with Solid Tumors
28. A Phase 1 Study of ABT-751, an Orally Bioavailable Tubulin Inhibitor, Administered Daily for 7 Days Every 21 Days in Pediatric Patients with Solid Tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.